Bio-Rad Laboratories (BIO) Income from Continuing Operations (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Income from Continuing Operations of 527100000.0 for Q1 2026, down 923.59% year-over-year from 64000000.0 in Q1 2025, and down 173.21% quarter-over-quarter from 720000000.0 in Q4 2025.
Bio-Rad Laboratories (BIO) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Income from Continuing Operations for 18 consecutive years, with 527100000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 923.59% year-over-year to 527100000.0; the TTM figure through Mar 2026 stood at 168800000.0 (up 107.8% YoY), while the FY2025 annual figure was 759900000.0, up 141.2% from the prior year.
- Income from Continuing Operations slipped to 527100000.0 in Q1 2026 per BIO's latest filing, from 720000000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 827814000.0 in Q4 2022 and bottomed at 3367347000.0 in Q1 2022.
- Historically, Income from Continuing Operations has averaged 345654058.82 across 5 years, with a median of 64000000.0 in 2025.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations jumped 514.74% — and 2026, when it tumbled 923.59%.
- Bio-Rad Laboratories' Income from Continuing Operations stood at 827814000.0 in 2022, then tumbled by 57.75% to 349736000.0 in 2023, then tumbled by 304.67% to 715800000.0 in 2024, then surged by 200.59% to 720000000.0 in 2025, then slumped by 173.21% to 527100000.0 in 2026.
- Business Quant data shows BIO's Income from Continuing Operations at 527100000.0 in Q1 2026, 720000000.0 in Q4 2025, and 341900000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Bio-Rad Laboratories | 9.99 Bn | 8.37 Bn | 345.80 Mn | 371.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 371.40 Mn |
| Mar 31, 2026 | -527.10 Mn |
| Dec 31, 2025 | 720.00 Mn |
| Sep 30, 2025 | -341.90 Mn |
| Jun 30, 2025 | 317.80 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Dec 31, 2024 | -715.80 Mn |
| Sep 30, 2024 | 653.20 Mn |
| Jun 30, 2024 | -2.17 Bn |
| Mar 31, 2024 | 383.90 Mn |
| Dec 31, 2023 | 349.74 Mn |
| Sep 30, 2023 | 106.26 Mn |
| Jun 30, 2023 | -1.16 Bn |
| Mar 31, 2023 | 68.96 Mn |
| Dec 31, 2022 | 827.81 Mn |
| Sep 30, 2022 | -162.81 Mn |
| Jun 30, 2022 | -925.11 Mn |
| Mar 31, 2022 | -3.37 Bn |
| Dec 31, 2021 | -1.57 Bn |
| Sep 30, 2021 | 3.93 Bn |